HAEMOPHILIA A
Clinical trials for HAEMOPHILIA A explained in plain language.
Never miss a new study
Get alerted when new HAEMOPHILIA A trials appear
Sign up with your email to follow new studies for HAEMOPHILIA A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pen aims to make haemophilia treatment easier to use
Disease control CompletedThis study tested whether a new, easier-to-use pen injector delivers the same amount of the haemophilia A treatment Mim8 into the blood as a traditional syringe. It involved 205 healthy men who received one injection under the skin. The goal is to make treatment administration si…
Matched conditions: HAEMOPHILIA A
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Apr 02, 2026 04:42 UTC
-
New hemophilia drug shows promise in reducing bleeding episodes
Disease control CompletedThis study tested how well a medicine called N8-GP works for preventing and treating bleeding episodes in Chinese patients with severe hemophilia A. Thirty-six male patients aged 12+ who had previously used other hemophilia treatments received N8-GP injections for 7-8 months. Res…
Matched conditions: HAEMOPHILIA A
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New injection could drastically cut bleeds for hemophilia patients
Disease control CompletedThis study tested a new medicine called Mim8, given as a weekly or monthly injection, to prevent bleeding episodes in people with hemophilia A. It compared Mim8 to other standard treatments in 281 adults and adolescents, including those whose bodies make inhibitors against standa…
Matched conditions: HAEMOPHILIA A
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hemophilia drug Mim8 tested for safe switch from current treatment
Disease control CompletedThis study checked if it was safe for people with hemophilia A to switch from their current preventive medicine, emicizumab, to a new one called Mim8. It involved 61 adults and adolescents who had been on emicizumab. Participants received Mim8 via a pen injector weekly, every two…
Matched conditions: HAEMOPHILIA A
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope for kids with severe bleeding disorder
Disease control CompletedThis study tested a medication called N8-GP in young children with severe hemophilia A who had never received treatment. The goal was to see if it was safe and effective at preventing bleeding episodes and stopping bleeds when they occurred. Researchers followed 124 boys under ag…
Matched conditions: HAEMOPHILIA A
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC